PR Newswire MOUNT LAUREL, N.J., Feb. 26, 2025 Epicur Pharma, a division of Stokes Healthcare and leading 503B outsourcing facility of veterinary medications, is proud to announce the addition of omeprazole injection suspension for horses to ...
PR Newswire EDINA, Minn., Feb. 26, 2025 The study also found high satisfaction with TDD for pain relief in patients with complex chronic pain EDINA, Minn., Feb. 26, 2025 /PRNewswire/ -- Nura Pain Clinics, a subsidiary of the Capitol Pain ...
PR Newswire SHANGHAI, Feb. 26, 2025 Bringing New Hope to Chinese Dialysis Patients with Hyperphosphatemia SHANGHAI, Feb. 26, 2025 /PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma; stock code: 600196.SH, ...
PR Newswire SUZHOU, China, Feb. 24, 2025 SUZHOU, China, Feb. 24, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer ...
PR Newswire MILWAUKEE, Feb. 24, 2025 Food allergic patients have better outcomes with omalizumab than oral immunotherapy MILWAUKEE, Feb. 24, 2025 /PRNewswire-PRWeb/ -- Food allergy treatment with omalizumab resulted in better outcomes ...
PR Newswire DOYLESTOWN, Pa., Feb. 24, 2025 DOYLESTOWN, Pa., Feb. 24, 2025 /PRNewswire/ -- Sterotherapeutics, a leading biopharmaceutical company dedicated to advancing innovative therapies, is announcing the launch of a Phase 2 clinical ...
PR Newswire LITTLETON, Colo., Feb. 24, 2025 DeFloria plans to initiate a Phase 2 clinical trial by mid-year 2025 LITTLETON, Colo., Feb. 24, 2025 /PRNewswire/ -- DeFloria, Inc., a collaboration between Ajna BioSciences PBC and Charlotte's ...
PR Newswire ZURICH, Feb. 24, 2025 ZURICH, Feb. 24, 2025 /PRNewswire/ -- Takeda (TSE: 4502) (NYSE: TAK) announced today that the EMA has approved an additional 2 mL pre-filled pen option for TAKHZYRO® (lanadelumab) for subcutaneous ...
PR Newswire RALEIGH, N.C., Feb. 24, 2025 RALEIGH, N.C., Feb. 24, 2025 /PRNewswire/ -- Kineticos Life Sciences announces the launch of Kinvard Bio, Inc., a newly established anti-infectives biotech company based on groundbreaking research ...
PR Newswire SILVER SPRING, Md., Feb. 21, 2025 SILVER SPRING, Md., Feb. 21, 2025 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Ctexli (chenodiol) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. ...
Lecanemab use is higher among white, male, urban, and wealthier patients despite broad Medicare coverage.
New antifungal nanotechnology uses targeted liposomes to boost drug delivery and fight Candida infections.
Real-world evidence shows long-term use of oral and inhaled steroids increases the risk of adrenal insufficiency, highlighting the need for proper treatment alternatives.
Legalizing and increased consumption of cannabis has led to increased cases of people visiting hospitals, many due to anxiety, psychosis, and other mental health disorders.
Glucagon-like peptide-1 receptor agonists improve cardiovascular outcomes and reduce mortality in patients with type 2 diabetes.
Subscribe to our Free Newsletters!
Medindia's policies are aligned with the United Nations Sustainable Development Goals (SDGs) - SDG 3, SDG 4, SDG 5, SDG 6 , SDG 10 & SDG 12.
Disclaimer - All information and content on this site are provided for informational and educational purposes only. They should NOT be used for the diagnosis or treatment of any health-related condition or disease. Always consult a qualified healthcare professional for medical advice, diagnosis, or treatment. Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers